A venture capital and private equity firm investing in medicine, biotechnology, medical technology, and diagnostics companies.
HBM Healthcare Investments AG prefers to invest in later-stage private companies that require financing for growing their company in Europe, Asia, and North America. Notable investments made by HBM Healthcare Investments AG include: Arcutis Biotherapeutics, 1mg, Viela Bio, Adrenomed, Galecto Biotech, Turning Point Therapeutics, CardiaLen, 4TEEN4 Pharmaceuticals, Galera Therapeutics, Jianke, PTC Therapeutics, AnaptysBio, Advanced Accelerator Applications, IVERIC Bio, Homology Medicines, ARMO BioSciences, and Aptinyx.